The U.S. government will give pharmaceutical company Moderna $176 million for a High Path Avian Flu vaccine, according to Reuters.
It uses the same technology as the COVID-19 vaccine, and Moderna began development and testing it last year on adults.
“mRNA vaccine technology offers advantages in efficacy, speed of development and production, scalability, and reliability in addressing infectious disease outbreaks, as demonstrated during the COVID-19 pandemic,” said Moderna CEO Stephane Bancel.
So far, four agriculture workers have contracted the virus since 2022.
Related Stories
The Arkansas Farm Bureau introduces us to the Brents Family, who have raised cattle, poultry, and hay on their operation in Jerusalem, Arkansas, for 14 years.
The California Farm Bureau introduces us to Aussie, its 2024 Farm Dog of the Year! Aussie’s proved nothing—not even the loss of a limb—can stop her from protecting her farm and family.
